Disease/Infection News

RSS

COVID-19 patients with traumatic injuries have six times higher risk of complications, death

In addition to sickening and taking the lives of millions across the globe, COVID-19 complicated patient care in a range of less-direct ways, from increased incidence of heart attacks to decreased cancer screenings.

28 Jun 2021

Tocilizumab and sarilumab shown to be effective in critical COVID-19

A new study, released as a preprint on the medRxiv* server, describes how a team of researchers from the University Medical Center Utrecht in the Netherlands explored the efficacy of four monoclonal antibodies that antagonize powerful pro-inflammatory pathways. The team sought to determine which were useful in treating critically ill COVID-19 patients on organ support.

28 Jun 2021

An affordable, scalable and highly sensitive virus-genome-based testing approach

Aiming to reduce human suffering, economic costs, and restrictions on personal freedom caused by COVID-19 to a minimum, researchers from Germany and Austria proposed an alternative method - efficient population-based genome-based testing.

28 Jun 2021

Oxford-AstraZeneca COVID-19 vaccine induces robust T cell-based immunity

A recent study conducted by an international team of scientists has revealed that the Oxford-AstraZeneca coronavirus disease 2019 (COVID-19) vaccine, AZD1222, is capable of inducing strong spike-specific CD4+ T cell helper type 1 (Th1) and CD8+ T-cell responses in vaccinated individuals. A detailed description of AZD1222-induced cellular immunity is currently available on the medRxiv* preprint server.

28 Jun 2021

Why SARS-CoV-2 delta variant is more infectious

German experts recently explained why the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant is more infectious and pathogenic than its ancestor. By conducting a series of in vitro experiments, they have revealed that increased ability to induce cell-to-cell fusion (syncytia) and reduced susceptibility to vaccine and infection-induced antibodies make the delta variant more infectious than previously circulating variants. The study is currently available on the bioRxiv* preprint server.

28 Jun 2021

An oral pill for COVID-19? Molnupiravir shows promise

Recently, researchers reported molnupiravir as the first oral and direct-acting antiviral that is highly effective at reducing SARS-CoV-2 levels.

27 Jun 2021

Swedish study reveals how long immunity lasts after mild COVID

As a result of the ongoing pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, the coronavirus disease 2019 (COVID-19), the global public health at risk has never been more dire.

27 Jun 2021

Why is staying active important during the COVID-19 pandemic?

Working from home is no excuse to stop exercising. New research led by Akira Ogami from the University of Occupational and Environmental Health in Japan confirms that regular exercise is needed in maintaining good physical and mental health during the COVID-19 pandemic. Workers who allocated time towards exercise or some form of physical activity reported a higher health-related quality of life than people who did not.

27 Jun 2021

Oxford study sheds light on level of antibodies needed to protect against COVID-19 symptoms

Researchers in the UK have reported on the relationship between humoral (antibody) responses and protection against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following immunization with AstraZeneca’s ChAdOx1 vaccine.

27 Jun 2021

Lambda lineage of SARS-CoV-2 has potential to become variant of concern

Researchers have described the first reported infection with the C.37 (Lambda) lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Southern Brazil.

27 Jun 2021

Georgia Tech’s dashboard breaks down Covid-19 vaccination trends by race at county level

The U.S. continues to see Covid-19 vaccinations gradually increasing nationwide, with nearly 66% of all adults now having at least one vaccine dose according to CDC's COVID Data Tracker, yet disparities have been noted in vaccination rates across races and geographic areas.

25 Jun 2021

Researchers find surprising differences in the way people use healthcare services during the pandemic

The COVID-19 pandemic has changed the way people eat, work, shop and go to school. Now, researchers from Japan have found surprising differences in the way people use healthcare services--including house calls from doctors.

25 Jun 2021

SARS-CoV-2 virus sequences could be identified from hospital surface swabs

A new study by UC Davis researchers confirms the low likelihood that SARS-CoV-2 contamination on hospital surfaces is infectious.

25 Jun 2021

UNC study provides important information for developing a viable vaccine against dengue

Developing a viable vaccine against dengue virus has proved difficult because the pathogen is actually four different virus types, or serotypes. Unless a vaccine protects against all four, a vaccine can wind up doing more harm than good.

25 Jun 2021

Novel biosensor offers rapid quantitative variant of concern-independent serology for SARS-CoV-2

Even as herculean efforts are being made to extend the reach of vaccination against COVID-19 to all the regions of the world, there is a dire need for rapid and sensitive tests to assess the antibody response to the various vaccines used and to monitor antibody titers over time. A new preprint describes a new approach to this problem which could be applied to other molecules of interest as well, both in laboratories and at the point of care.

25 Jun 2021

Study examines safety of COVID-19 vaccination during lactation

A new preprint, recently released on the medRxiv* server, reports from real life in a cohort of mother-child dyads in Singapore. The mothers were lactating after having received COVID-19 vaccination.

25 Jun 2021

Evaluation of COVID-19 vaccination effects on outbreak dynamics in Japan

Among the developed nations, Japan was the last to commence vaccination (February 2021). Only 8.7% of Japanese people are fully vaccinated as of today, June 25th, 2021. Fortunately for Japan, the incidence of the disease has been much lower than in Europe or the United States. Now, a new study published on the medRxiv* preprint server analyzes the impact of vaccination on the COVID-19 outbreak in Japan

25 Jun 2021

Multisystem Inflammatory Syndrome in Children significantly affects more Black and Latino children

Multisystem Inflammatory Syndrome in Children (MIS-C) significantly affected more Black and Latino children than white children, with Black children at the highest risk, according to a new observational study of 124 pediatric patients treated at Children's National Hospital in Washington, D.C.

25 Jun 2021

Sleep-wake behavior predicts mental health resilience during COVID-19

Now, a group of researchers from the USA and Australia has collaborated on a study analyzing objective sleep-wake data and the effect of COVID-19 on the mental health of adults in the USA.

25 Jun 2021

Researchers model infection-spreading scenarios to understand the impact of COVID-19

Researchers at the Niels Bohr Institute, University of Copenhagen, together with epidemiologist Lone Simonsen from Roskilde University form part of the panel advising the Danish government on how to tackle the different infection-spreading situations we have all seen unfold over the past year.

25 Jun 2021

Disease/Infection News

COVID-19 patients with traumatic injuries have six times higher risk of complications, death

Tocilizumab and sarilumab shown to be effective in critical COVID-19

An affordable, scalable and highly sensitive virus-genome-based testing approach

Oxford-AstraZeneca COVID-19 vaccine induces robust T cell-based immunity

Why SARS-CoV-2 delta variant is more infectious

An oral pill for COVID-19? Molnupiravir shows promise

Swedish study reveals how long immunity lasts after mild COVID

Why is staying active important during the COVID-19 pandemic?

Oxford study sheds light on level of antibodies needed to protect against COVID-19 symptoms

Lambda lineage of SARS-CoV-2 has potential to become variant of concern

Georgia Tech’s dashboard breaks down Covid-19 vaccination trends by race at county level

Researchers find surprising differences in the way people use healthcare services during the pandemic

SARS-CoV-2 virus sequences could be identified from hospital surface swabs

UNC study provides important information for developing a viable vaccine against dengue

Novel biosensor offers rapid quantitative variant of concern-independent serology for SARS-CoV-2

Study examines safety of COVID-19 vaccination during lactation

Evaluation of COVID-19 vaccination effects on outbreak dynamics in Japan

Multisystem Inflammatory Syndrome in Children significantly affects more Black and Latino children

Sleep-wake behavior predicts mental health resilience during COVID-19

Researchers model infection-spreading scenarios to understand the impact of COVID-19

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News